A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome

This prospective observational study evaluated the efficacy and safety of long-term decitabine treatment in patients with myelodysplastic syndrome (MDS). Decitabine 20 mg/m(2)/day was administered intravenously for 5 consecutive days every 4 weeks to MDS patients in intermediate-1 or higher Internat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Jeong, Seong Hyun, Kim, Yoo-Jin, Lee, Je-Hwan, Kim, Yeo-Kyeoung, Kim, Soo Jeong, Park, Sung Kyu, Do, Young Rok, Kim, Inho, Mun, Yeung-Chul, Kim, Hoon Gu, Lee, Won Sik, Yi, Hyeon Gyu, Joo, Young-Don, Choi, Chul Won, Kim, Suk Ran, Na, Sang Min, Jang, Jun Ho
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2015
Pynciau:
Clinical Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792606/
https://ncbi.nlm.nih.gov/pubmed/26517692
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg